Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats.
暂无分享,去创建一个
Sung-Ho Kim | S. Kang | Jong-Choon Kim | B. Jang | M. Chung | Dong-ho Shin | Choong‐Yong Kim | T. Ahn
[1] M. Chung,et al. Developmental toxicity of flupyrazofos, a new organophosphorus insecticide, in rats. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[2] Ho-Chul Shin,et al. Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy. , 2001, Life sciences.
[3] R. Lochmiller,et al. Evaluation Of Myelotoxicity In Cotton Rats (Sigmodon hispidus) Exposed To Environmental Contaminants. I. In Vitro Bone-Marrow Progenitor Culture , 2001, Journal of toxicology and environmental health. Part A.
[4] Ho-Chul Shin,et al. Embryo lethality and teratogenicity of a new fluoroquinolone antibacterial DW-116 in rats , 2000, Archives of Toxicology.
[5] T. Gootz,et al. Chemistry and Mechanism of Action of the Quinolone Antibacterials , 2000 .
[6] I. Chahoud,et al. Correlation between maternal toxicity and embryo/fetal effects. , 1999, Reproductive toxicology.
[7] K. Imai,et al. Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administration. , 1999, Teratogenesis, carcinogenesis, and mutagenesis (Print).
[8] C. Meyerhoff,et al. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects. , 1998, The Journal of antimicrobial chemotherapy.
[9] J. C. Kim,et al. Embryotoxic effects of SKI 2053R, a new potential anticancer agent, in rats. , 1998, Reproductive toxicology.
[10] T. Inagaki,et al. The cytotoxic effects of fleroxacin and ciprofloxacin on transitional cell carcinoma in Vitro , 1997, Cancer.
[11] C. Mitoma,et al. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[12] C. Shim,et al. Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats. , 1997, Journal of pharmaceutical sciences.
[13] R. G. York,et al. Terminology of developmental abnormalities in common laboratory mammals (version 1). , 1997, Teratology.
[14] E. Choi,et al. In-vitro and in-vivo activities of DW-116, a new fluoroquinolone. , 1997, The Journal of antimicrobial chemotherapy.
[15] Y. Shindo,et al. [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(2)--A teratogenicity study in rats by oral administration] , 1996 .
[16] M. Hirohashi,et al. Toxicity of quinolone antimicrobial agents. , 1995, Journal of toxicology and environmental health.
[17] V. Tullio,et al. Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results. , 1994, The Journal of antimicrobial chemotherapy.
[18] H. Neu,et al. Quinolone antimicrobial agents. , 1992, Annual review of medicine.
[19] D. Hooper,et al. Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.
[20] R. Kavlock,et al. An overview of maternal toxicity and prenatal development: considerations for developmental toxicity hazard assessments. , 1989, Toxicology.
[21] K. Khera. Maternal toxicity in humans and animals: effects on fetal development and criteria for detection. , 1987, Teratogenesis, carcinogenesis, and mutagenesis.
[22] C. Kimmel,et al. Skeletal deviations in rats: malformations or variations? , 1973, Teratology.
[23] J. Wilson. Methods for administering agents and detecting malformations in experimental animals , 1965 .
[24] A. B. Dawson. A Note on the Staining of the Skeleton of Cleared Specimens with Alizarin Red S , 1926 .